On the Utility of MIBG SPECT/CT in Evaluating Cardiac Sympathetic Dysfunction in Lewy Body Diseases

BACKGROUND: Abnormal cardiac uptake of (123)I-metaiodobenzylguanidine ((123)I-MIBG) is a diagnostic marker of Lewy body diseases (LBDs), e.g., Parkinson’s disease (PD) and dementia with Lewy bodies (DLB). Planar imaging is generally used to assess cardiac sympathetic dysfunction in (123)I-MIBG scint...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:PLoS One
Glavni autori: Odagiri, Hayato, Baba, Toru, Nishio, Yoshiyuki, Iizuka, Osamu, Matsuda, Minoru, Inoue, Kentaro, Kikuchi, Akio, Hasegawa, Takafumi, Aoki, Masashi, Takeda, Atsushi, Taki, Yasuyuki, Mori, Etsuro
Format: Artigo
Jezik:Inglês
Izdano: Public Library of Science 2016
Teme:
Research Article
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC4824520/
https://ncbi.nlm.nih.gov/pubmed/27055151
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0152746
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items